Patent Law Weblog
recent posts
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
- United States Files Statement of Interest in Patent Infringement Proceedings
about
Month: December 2007
-
By Donald Zuhn — Yesterday, we counted down the first third of the top fifteen stories that were covered on Patent Docs in 2007 (see "Top Stories of 2007: #15 to #11"). Today, we count down stories #10 to #6, and tomorrow, we will count down the top five stories. In case you…
-
By Donald Zuhn — It is natural at this time of year to reflect upon the events of the past twelve months in the hope that such a review might provide some indication of what to expect in the coming year. In order to help focus on possible developments in biotech and pharma…
-
By Baltazar Gomez — We previously reported on the passage by the U.S. Senate Committee on Health, Education, Labor & pensions of bill S.1695, entitled "The Biologics Price Competition and Innovation Act of 2007." The bill’s sponsors stated that the bill reflects a balanced approach that enables patients to have safe and effective…
-
By Robert Dailey — ActivBiotics announced last week that it is auctioning off substantially all of its assets following the failed clinical trial of its cardiovascular drug Rifalazil. Rifalazil, a bactericidal anti-chlamidial agent, had been placed on the FDA’s Fast Track just one year ago. The drug had shown initial promise as a…
-
By Christopher P. Singer — In the December 26, 2007 Federal Register, the USPTO announced that it will discontinue publishing the paper form of the Official Gazette, after the December 25, 2007 publication. The weekly USTPO notices will be published in the electronic Official Gazette (the eOG:P) and will display the notices with…
-
By Christopher P. Singer — In a December 21, 2007 press release, the U.S. Patent and Trademark Office announced that the U.S. and Japan Patent Offices will implement the pilot Patent Prosecution Highway (PPH) program on a full-time basis, effective January 4, 2008. The pilot program demonstrated the potential that the full-time program…
-
By Kevin E. Noonan — Ophthalmologists and Genentech have forged a compromise over the availability of Genentech’s anticancer drug, Avastin®, for use in treating neovascular or "wet" age-related macular degeneration (AMD). The controversy arose when Genentech decided to ban compounding pharmacies from reformulating Avastin® (bevacizumab, a monoclonal antibody) to be used for treating…
-
The authors and contributors of Patent Docs wish their readers a Happy Holidays. Publication of Patent Docs will resume on December 26th.
-
By Donald Zuhn — On Tuesday, Senators Patrick Leahy (D-VT), the Chairman of the Senate Judiciary Committee, and Orrin Hatch (R-UT) engaged in a brief but enlightening discussion on the Senate floor regarding the state of Senate’s patent reform bill. Senator Leahy, the sponsor of the Senate patent reform bill (S.1145), opened the…
-
By Donald Zuhn — It took a bit longer than many members of the patent bar expected, but the new continuation and claims rules, which were preliminarily enjoined on October 31st by Judge James Cacheris of the U.S. District Court for the Eastern District of Virginia, and the patent reform bills passed by…
Patent Docs 